False-positive mammograms may result in women delaying their next screening mammogram.
Women who receive a false-positive mammogram are more likely to delay subsequent screenings compared with women who have true negative mammograms, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
Researchers from the University of Illinois at Chicago undertook the study to examine the impact of a false-positive screening mammogram on subsequent screening mammography behavior, such as a delay of more than 12 months from index mammogram to the next one, and resulting cumulative risk.
Data from 741,150 screening mammograms from 261,767 women were obtained through a large health care organization with multiple facilities in the greater metropolitan Chicago area. Of these mammograms, 12.3% (90,918 exams) yielded a false positive result, the remaining 87.7% (650,232 exams) yielded true negative results.
The results from the database showed that receiving a false-positive mammogram did result in delays for subsequent screening:
*This difference was statistically significant.
"Because we obtained the same conclusion using two different statistical approaches to analyze the data, we have a high degree of confidence in the results," Firas M. Dabbous, PhD, manager of patient centered outcomes research at the Russell Institute for Research & Innovation at the Advocate Lutheran General Hospital in Park Ridge, Illinois, said in a release. "We believe that the delay in subsequent screening for women who have an initial false positive result increases the probability that they will subsequently receive a later-stage breast cancer diagnosis compared with women who first have a true negative result from a screening mammogram."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.